CC
DNA icon

Centiva Capital’s Ginkgo Bioworks DNA Stock Holding History

Centiva Capital’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,861
Closed -$252K – 2256
2024
Q2 		$252K Buy
+18,861
New +$563K ﹤0.01% 1557
2023
Q4 		– Sell
-750
Closed -$54.3K – 1899
2023
Q3 		$54.3K Buy
+750
New +$60K ﹤0.01% 1595
2022
Q3 		– Sell
-1,036
Closed -$99K – 1566
2022
Q2 		$99K Buy
+1,036
New +$126K ﹤0.01% 1430

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Centiva Capital's DNA Position: Q3 2024 in Review

Centiva Capital sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 18,861 shares — an estimated $252K sold.

Centiva Capital first reported a position in DNA in Q2 2022 and held it in 3 quarters. The position peaked at $252K in Q2 2024. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Centiva Capital reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Centiva Capital sold 18,861 Ginkgo Bioworks shares in Q3 2024, an estimated $252K.
  • Centiva Capital first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 3 quarters.
  • Centiva Capital's Ginkgo Bioworks position peaked at $252K in Q2 2024.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.